Immunomodulatory effects of fetal and adult mesenchymal stem cells

被引:459
作者
Le Blanc, K [1 ]
机构
[1] Huddinge Univ Hosp, Dept Immunol, Div Clin Immunol, Ctr Allogen Stem Cell Transplantat, SE-14186 Stockholm, Sweden
关键词
D O I
10.1080/14653240310003611
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Mesenchymal stem cells ( MSC) derived from adult BM or fetal liver form several mesenchymal tissues after appropriate stimulation. Reports indicate that MSC have unique immunologic properties, making them ideal for cellular therapy. MSC are not immunogenic, they do not stimulate alloreactivity, and they escape lysis by cytotoxic T-cells and natural killer (NK)-cells. Thus, MSC may be transplantable between HLA-mismatched individuals without the need for host immunosuppression. Furthermore, adult MSC appear to be immunosuppressive as they reduce alloreactivity and the formation of cytotoxic lymphocytes in vitro. In vivo, adult MSC prolong the time to rejection of mis-matched skin grafts in baboons. The immunosuppressive properties of first trimester fetal MSC are less pronounced, but inducible with IFNgamma. These findings imply a potential role for MSC, not only in the repair of damaged tissues, but also in the manipulation of immune responses.
引用
收藏
页码:485 / 489
页数:5
相关论文
共 32 条
  • [1] Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice
    Angelopoulou, M
    Novelli, E
    Grove, JE
    Rinder, HM
    Civin, C
    Cheng, LZ
    Krause, DS
    [J]. EXPERIMENTAL HEMATOLOGY, 2003, 31 (05) : 413 - 420
  • [2] Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo
    Bartholomew, A
    Patil, S
    Mackay, A
    Nelson, M
    Buyaner, D
    Hardy, W
    Mosca, J
    Sturgeon, C
    Siatskas, M
    Mahmud, N
    Ferrer, K
    Deans, R
    Moseley, A
    Hoffman, R
    Devine, SM
    [J]. HUMAN GENE THERAPY, 2001, 12 (12) : 1527 - 1541
  • [3] Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
    Bartholomew, A
    Sturgeon, C
    Siatskas, M
    Ferrer, K
    McIntosh, K
    Patil, S
    Hardy, W
    Devine, S
    Ucker, D
    Deans, R
    Moseley, A
    Hoffman, R
    [J]. EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) : 42 - 48
  • [4] Transplantation of the bone marrow microenvironment leads to hematopoietic chimerism without cytoreductive conditioning
    Bingaman, AW
    Waitze, SY
    Alexander, DZ
    Cho, HR
    Lin, A
    Tucker-Burden, C
    Cowan, SR
    Pearson, TC
    Larsen, CP
    [J]. TRANSPLANTATION, 2000, 69 (12) : 2491 - 2496
  • [5] Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow
    Campagnoli, C
    Roberts, IAG
    Kumar, S
    Bennett, PR
    Bellantuono, I
    Fisk, NM
    [J]. BLOOD, 2001, 98 (08) : 2396 - 2402
  • [6] Mesenchymal stem cells: Biology and potential clinical uses
    Deans, RJ
    Moseley, AB
    [J]. EXPERIMENTAL HEMATOLOGY, 2000, 28 (08) : 875 - 884
  • [7] Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion
    Devine, SM
    Bartholomew, AM
    Mahmud, N
    Nelson, M
    Patil, S
    Hardy, W
    Sturgeon, C
    Hewett, T
    Chung, T
    Stock, W
    Sher, D
    Weissman, S
    Ferrer, K
    Mosca, J
    Deans, R
    Moseley, A
    Hoffman, R
    [J]. EXPERIMENTAL HEMATOLOGY, 2001, 29 (02) : 244 - 255
  • [8] Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates
    Devine, SM
    Cobbs, C
    Jennings, M
    Bartholomew, A
    Hoffman, R
    [J]. BLOOD, 2003, 101 (08) : 2999 - 3001
  • [9] Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
    Di Nicola, M
    Carlo-Stella, C
    Magni, M
    Milanesi, M
    Longoni, PD
    Matteucci, P
    Grisanti, S
    Gianni, AM
    [J]. BLOOD, 2002, 99 (10) : 3838 - 3843
  • [10] Frassoni F, 2002, BONE MARROW TRANSPL, V29, pS2